Medtronic (MDT) Stock Price, News & Analysis

Company Overview

Medtronic plc is a global medical technology company that develops and manufactures devices, therapies and healthcare solutions for treating chronic and acute conditions. Its products are used in areas including cardiac and vascular care, neuroscience, medical and surgical procedures, and diabetes management.

The company’s portfolio includes pacemakers, implantable cardioverter-defibrillators, cardiac ablation systems, stents and other cardiovascular products; neuromodulation systems, deep-brain stimulation devices and spinal technologies; surgical instruments, robotic-assisted surgery systems and gastrointestinal diagnostic tools; and insulin pumps and related diabetes technologies.

Medtronic traces its origins to 1949, when Earl Bakken and Palmer Hermundslie founded the company in Minneapolis, Minnesota. Bakken later developed the first battery-powered external wearable pacemaker, helping establish Medtronic as a major medical device innovator. The company serves healthcare providers and patients in markets around the world, with operations and products spanning North America, Europe, Asia-Pacific and other international regions.

Geoffrey S. Martha serves as Medtronic’s chairman and chief executive officer. The company is incorporated in Ireland and maintains significant corporate and operational activities in the United States, including in Minnesota.

Key Stats

• Today's Range: $87.52 to $89.53
• 50-Day Range: $82.00 to $94.13
• 52-Week Range: $73.31 to $106.33
• Volume: 22.55 million shs
• Average Volume: 9.63 million shs
• Market Capitalization: $114.41 billion
• P/E Ratio: 22.03
• Dividend Yield: 3.22%
• Price Target: $103.92
• Consensus Rating: Moderate Buy

Medtronic Stock Analysis - MarketRank™

Medtronic scored higher than 95% of companies evaluated by MarketBeat, and ranked 14th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.68, and is based on no strong buy ratings, 19 buy ratings, 9 hold ratings, and no sell ratings.

Upside Potential

Medtronic has a consensus price target of $103.92, representing about 16.2% upside from its current price of $89.44.

Amount of Analyst Coverage

Medtronic has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.35%

Earnings Growth

Earnings for Medtronic are expected to grow by 6.35% in the coming year, from $5.98 to $6.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medtronic is 22.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.82.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medtronic is 22.03, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.05.

Price to Earnings Growth Ratio

Medtronic has a PEG Ratio of 2.02. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Medtronic has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.35% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1.97, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently increased by 41.99%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Medtronic pays a meaningful dividend of 3.25%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Medtronic has been increasing its dividend for 49 years.

Dividend Coverage

The dividend payout ratio of Medtronic is 70.94%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Medtronic will have a dividend payout ratio of 45.28% next year. This indicates that Medtronic will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.3 / 5
• News Sentiment: 0.85

News Sentiment

Medtronic has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 32 news articles for Medtronic this week, compared to 9 articles on an average week.

Search Interest

65 people have searched for MDT on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days.

MarketBeat Follows

31 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 121% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Medtronic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $138,883.00 in company stock.

Percentage Held by Insiders

0.27% of the stock of Medtronic is held by insiders.

Percentage Held by Institutions

82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 7/17 Dividend: 6/26/2026
• Ex-Dividend for 7/17 Dividend: 6/26/2026
• Dividend Payable: 7/17/2026
• Last Earnings: 9/01/2026
• Record date for 10/16 Dividend: 9/25/2026
• Ex-Dividend for 10/16 Dividend: 9/25/2026
• Today: 9/28/2026
• Dividend Payable: 10/16/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:MDT
• CIK: 1613103
• Web: www.medtronic.com
• Phone: (531) 438-1700
• Fax: 763-514-4879
• Employees: 95,000
• Year Founded: 1949

Price Target and Rating

• Average Price Target for Medtronic: $103.92
• High Price Target: $120.00
• Low Price Target: $83.00
• Potential Upside/Downside: +16.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.68
• Research Coverage: 28 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.06
• Trailing P/E Ratio: 22.03
• Forward P/E Ratio: 14.96
• P/E Growth: 2.02
• Net Income: $4.80 billion
• Net Margins: 13.93%
• Pretax Margin: 17.59%
• Return on Equity: 14.78%
• Return on Assets: 7.97%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 2.07
• Quick Ratio: 1.54

Sales & Book Value

• Annual Sales: $36.36 billion
• Price / Sales: 3.15
• Cash Flow: $7.92 per share
• Price / Cash Flow: 11.29
• Book Value: $39.00 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 1,279,140,000
• Free Float: 1,275,684,000
• Market Cap: $114.41 billion
• Optionable: Optionable
• Beta: 0.56